Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 644,421.0 | $5.6M | 3.52% | -22K | -3.3% | $8.67 | -0.7% |
| 2 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 131,364.0 | $4.1M | 2.61% | -23K | -14.9% | $31.48 | -2.0% |
| 3 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 742,049.0 | $4.1M | 2.60% | -120K | -13.9% | $5.55 | +120.3% |
| 4 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 210,163.0 | $4.1M | 2.58% | -72K | -25.6% | $19.45 | -12.6% |
| 5 | IVA | INVENTIVA SA | Healthcare | 724,678.0 | $4.0M | 2.52% | -275K | -27.5% | $5.51 | -6.4% |
| 6 | — | OCULIS HOLDING AG | — | 122,223.0 | $3.3M | 2.07% | -51K | -29.3% | $26.83 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
75.4%
Energy
24.6%